| Followers | 51 |
| Posts | 13651 |
| Boards Moderated | 0 |
| Alias Born | 06/15/2014 |
Friday, October 25, 2024 6:48:08 PM
Recent AMRN News
- New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients • GlobeNewswire Inc. • 11/09/2025 09:15:00 PM
- Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025 • GlobeNewswire Inc. • 11/03/2025 01:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2025 08:30:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/29/2025 11:05:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2025 11:05:27 AM
- Amarin Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 10/29/2025 11:00:00 AM
- Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit • GlobeNewswire Inc. • 10/27/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2025 09:00:31 PM
- Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025 • GlobeNewswire Inc. • 10/15/2025 12:00:00 PM
- Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress • GlobeNewswire Inc. • 10/14/2025 12:00:00 PM
- Amarin Shares Rise on ESC Congress Data Highlighting VASCEPA Mechanism • IH Market News • 09/02/2025 02:14:24 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025 • GlobeNewswire Inc. • 08/31/2025 12:30:00 PM
- New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups • GlobeNewswire Inc. • 08/30/2025 12:30:00 PM
- New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025 • GlobeNewswire Inc. • 08/25/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/04/2025 09:00:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/30/2025 11:05:53 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2025 11:05:29 AM
- Amarin Reports Second Quarter 2025 Financial Results • GlobeNewswire Inc. • 07/30/2025 11:00:00 AM
- Form F-6 - Registration of American Depository Receipt shares, not immediately effective • Edgar (US Regulatory) • 07/23/2025 01:02:53 PM
- Amarin to Report Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025 • GlobeNewswire Inc. • 07/23/2025 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/01/2025 01:30:04 AM
- Amarin Stock Surges 11% After $25 Million Licensing Deal with Recordati • IH Market News • 06/24/2025 02:09:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/24/2025 11:05:28 AM
- Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe • GlobeNewswire Inc. • 06/24/2025 11:00:00 AM
One World Products (to become Isiah Enterprises) Targets December Operational Breakeven; 250,000+ Pounds of Pelletized Rubber Shipped • OWPC • Dec 10, 2025 11:24 AM
Growing Momentum Signals Opportunity as Explorers Shift Toward Production, Reveal Substantial Value • LFLRF • Dec 10, 2025 9:00 AM
Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership • BLEG • Dec 10, 2025 9:00 AM
Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing • BLO • Dec 9, 2025 8:45 AM
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival • AVAI • Dec 9, 2025 8:00 AM
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value • B • Dec 8, 2025 9:00 AM
